Trial Profile
Immediate or early salvage post-operative external radiotherapy combined with concomitant and adjuvant hormonal treatment versus immediate or early salvage postoperative external radiotherapy alone in pT3a-b R0-1 cN0M0 / pT2R1 cN0M0, Gleason score 5-10 prostatic carcinoma. A Phase III study
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary) ; Antiandrogens
- Indications Prostate cancer
- Focus Therapeutic Use
- 02 Apr 2022 This trial has been completed in France (End Date: 5 Jan 2014) according to European Clinical Trials Database record.
- 03 Jul 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 27 Jun 2012 Additional trial locations added as reported by European Clinical Trials Database.